Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

GM Plants To Grow Vaccines Against Killer Diseases

18.03.2005


Genetically modified (GM) plants are to be used to grow vaccines for use in the worldwide fight against HIV, tuberculosis, diabetes and rabies thanks to a grant of 12 million euros from the EU’s Sixth Framework Programme (FP6).



‘Pharma-Planta’ draws on the expertise and experience of 39 scientists from 11 European countries and South Africa to address significant health problems affecting Europe and the developing world - although the primary aim is to provide medicines for poorer countries.

In the first international project of its kind, ‘Pharma-Planta’ will develop the concept from plant modification through to clinical trials and they expect to begin human trials of the drugs within four years.


“We are addressing the serious issue of global inequality of health”, says scientific coordinator, Professor Julian Ma from St George’s Hospital Medical School in London. “Although the major burden of 21st century disease is in the developing world we have to accept it as a global problem as these are the countries that do not have access to vaccines.

“We know we can use GM technology to force a plant’s molecular apparatus to produce a range of medically useful compounds. Already genetic modification of other organisms is being used to produce human insulin and a hepatitis B vaccine. However, plant derived materials used in humans have never been formally addressed within the EU. So, this is a ground-breaking project that aims to provide help for the millions of people that die each year throughout the world from vaccine preventable diseases.”

Because plants are inexpensive to grow they could be used to produce large quantities of drugs or vaccines at low cost - anywhere between 10 and 100 times lower than conventional production, which is often labour intensive, expensive and often produces relatively small amounts of pharmaceuticals.

If the project is successful, the techniques would be licensed to developing countries. They would then be able to start up their own production to generate whatever amount they require at a cost that would not impact greatly on the countries economy.

Although the project has not finally decided which plants will be used, the likely candidates are tobacco or maize.

“The ‘Pharma-Planta’ project is an excellent example of how EU Framework Funding is being used to help research and development projects that will have a major impact on the everyday lives of people both in Europe and around the world”, says Claire Horton FP6UK’s National Contact Point for ’Life sciences, genomics and biotechnology for health. “This funding helps bring together experts from different countries to work together in the fight against diseases that can affect us all.

“The current Framework Programme (FP6) runs until 2006 and organisations wanting free information on how to access some of the 19 billion euros available should log on to http://fp6uk.ost.gov.uk or call central telephone support on 0870 600 6080.”

Dave Sanders | alfa
Further information:
http://fp6uk.ost.gov.uk

More articles from Agricultural and Forestry Science:

nachricht Six-legged livestock -- sustainable food production
11.05.2017 | Faculty of Science - University of Copenhagen

nachricht Elephant Herpes: Super-Shedders Endanger Young Animals
04.05.2017 | Universität Zürich

All articles from Agricultural and Forestry Science >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>